Modeling type II collagenopathy skeletal dysplasia by directed conversion and induced pluripotent stem cells

Human Molecular Genetics

Volumn 24, Issue 2, 2015, Pages 299-313

  Okada, Minoru ^a   Ikegawa, Shiro ^b   Morioka, Miho ^a   Yamashita, Akihiro ^a   Saito, Atsushi ^c   Sawai, Hideaki ^d   Murotsuki, Jun ^e   Ohashi, Hirofumi ^f   Okamoto, Toshio ^g   Nishimura, Gen ^h   Imaizumi, Kazunori ^c   Tsumaki, Noriyuki ^a,i  

^a KYOTO UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^g ASAHIKAWA MEDICAL COLLEGE   (Japan)

^h TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

ⁱ JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COLLAGEN TYPE 2; COL2A1 PROTEIN, HUMAN; COL2A1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE DYSPLASIA; CARTILAGE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL VIABILITY; CHONDROGENESIS; COLLAGEN DISEASE; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TERATOMA; TYPE II COLLAGENOPATHY SKELETAL DYSPLASIA; ANIMAL; CELL CULTURE; CHONDRODYSPLASIA; CYTOLOGY; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

IPS; MUS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; OSTEOCHONDRODYSPLASIAS;

EID: 84922478971     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu444     Document Type: Article

References (28)

1. Olsen, B.R., Reginato, A.M. and Wang, W. (2000) Bonedevelopment. Annu. Rev. Cell Dev. Biol., 16, 191-220.
2. Khoshnoodi, J., Cartailler, J.-P., Alvares, K., Veis, A. and Hudson, B.G. (2006) Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers. J. Biol. Chem., 281, 38117-38121.
3. Kielty, C.M., Hopkinson, I. and Grant, M.E. (1993) In Royce, P.M. and Steinmann, B. (eds), Connective Tissue and its Heritable Disorders: Molecular, Genetic, and Medical Aspects. Wiley-Liss, Inc., New York, pp. 103-147.
4. Warman, M.L., Cormier-Daire, V., Hall, C., Krakow, D., Lachman, R., LeMerrer, M., Mortier, G., Mundlos, S., Nishimura, G., Rimoin, D.L. et al. (2011) Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. Part A, 155A, 943-968.
5. Ala-Kokko, L., Baldwin, C.T., Moskowitz, R.W. and Prockop, D.J. (1990) Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc. Natl Acad. Sci. USA, 87, 6565-6568.
6. Zankl, A., Zabel, B., Hilbert, K., Wildhardt, G., Cuenot, S., Xavier, B., Ha-Vinh, R., Bonafé, L., Spranger, J. and Superti-Furga, A. (2004) Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am. J. Med. Genet. Part A, 129A, 144-148.
7. Bateman, J.F., Boot-Handford, R.P. and Lamandé, S.R. (2009) Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations. Nat. Rev. Genet., 10, 173-183.
8. Tsang, K.Y., Chan, D., Bateman, J.F. and Cheah, K.S.E. (2010) In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J. Cell Sci., 123, 2145-2154.
9. Furuichi, T., Masuya, H., Murakami, T., Nishida, K., Nishimura, G., Suzuki, T., Imaizumi, K., Kudo, T., Ohkawa, K., Wakana, S. et al. (2011) ENU-induced missense mutation in the C-propeptide coding region of Col2a1 creates a mouse model of platyspondylic lethal skeletal dysplasia, Torrance type. Mammalian Genome: Official Journal of the International Mammalian Genome Society, 22, 318-328.
10. Hintze, V., Steplewski, A., Ito, H., Jensen, D.a., Rodeck, U. and Fertala, A. (2008) Cells expressing partially unfolded R789C/p.R989C type II procollagen mutant associated with spondyloepiphyseal dysplasia undergo apoptosis. Hum. Mutat., 29, 841-851.
11. Aigner, T., Cook, J.L., Gerwin, N., Glasson, S.S., Laverty, S., Little, C.B., McIlwraith, W. and Kraus, V.B. (2010) Histopathology atlas of animal model systems - overview of guiding principles. Osteoarth. Cartil., 18(Suppl. 3), S2-S6.
12. Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O.J., Navarrete, E.G., Hu, S., Wang, L., Lee, A. et al. (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Translat. Med., 4, 130ra147.
13. Israel, M.a., Yuan, S.H., Bardy, C., Reyna, S.M., Mu, Y., Herrera, C., Hefferan, M.P., Van Gorp, S., Nazor, K.L., Boscolo, F.S. et al. (2012) Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature, 482, 216-220.
14. Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., Adachi, F., Kondo, T., Okita, K., Asaka, I. et al. (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Translat. Med., 4, 145ra104-145ra104.
15. Qiang, L., Fujita, R., Yamashita, T., Angulo, S., Rhinn, H., Rhee, D., Doege, C., Chau, L., Aubry, L., Vanti, W.B. et al. (2011) Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell, 146, 359-371.
16. Hiramatsu, K., Sasagawa, S., Outani, H., Nakagawa, K., Yoshikawa, H. and Tsumaki, N. (2011) Generationof hyaline cartilaginous tissue frommouse adult dermal fibroblast culture by defined factors. J. Clin. Invest., 121, 640-657.
17. Outani, H., Okada, M., Yamashita, A., Nakagawa, K., Yoshikawa, H. and Tsumaki, N. (2013) Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors. PLoS ONE, 8, e77365.
18. Outani, H., Okada, M., Hiramatsu, K., Yoshikawa, H. and Tsumaki, N. (2011) Induction of chondrogenic cells from dermal fibroblast culture by defined factors does not involve a pluripotent state. Biochem. Biophys. Res. Commun., 411, 607-612.
19. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A. and de Crombrugghe, B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 16, 2813-2828.
20. Lefebvre, V., Li, P. and de Crombrugghe, B. (1998) Anewlong form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J., 17, 5718-5733.
21. Smits, P., Li, P., Mandel, J., Zhang, Z., Deng, J.M., Behringer, R.R., de Crombrugghe, B. and Lefebvre, V. (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell, 1, 277-290.
22. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
23. Oldershaw, R.A., Baxter, M.A., Lowe, E.T., Bates, N., Grady, L.M., Soncin, F., Brison, D.R., Hardingham, T.E. and Kimber, S.J. (2010) Directed differentiation of human embryonic stem cells toward chondrocytes. Nat. Biotechnol., 28, 1187-1194.
24. Lee, H.S., Doh, J.W., Kim, C.J. and Chi, J.G. (2000) Achondrogenesis type II (Langer-Saldino achondrogenesis): a case report. J. Korean Med. Sci., 15, 604-608.
25. Chan, D., Cole, W.G., Chow, C.W., Mundlos, S. and Bateman, J.F. (1995) A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage. J. Biol. Chem., 270, 1747-1753.
26. Bandyopadhyay, A., Saxena, K., Kasturia, N., Dalal, V., Bhatt, N., Rajkumar, A., Maity, S., Sengupta, S. and Chakraborty, K. (2012) Chemical chaperones assist intracellular folding to buffer mutational variations. Nat. Chem. Biol., 8, 238-245.
27. Ishida, Y., Yamamoto, A., Kitamura, A., Lamande, S.R., Yoshimori, T., Bateman, J.F., Kubota, H. and Nagata, K. (2009) Autophagic elimination of misfolded procollagen aggregates in the endoplasmic reticulum as a means of cell protection. Mol. Biol. Cell, 20, 2744-2754.
28. Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K. et al. (2011) A more efficient method to generate integration-free human iPS cells. Nat. Methods, 8, 409-412.